Joint (JYNT) Stock Chart & Stock Price History → The #1 Biotech Stock to Have on Your Radar in 2024… (From Huge Alerts) (Ad) Free JYNT Stock Alerts $12.28 -0.31 (-2.46%) (As of 04/24/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Joint Stock Price Performance5 Day Performance+0.82%1 Month Performance-5.32%3 Month Performance+30.78%6 Month Performance+49.76%Year-To-Date Performance+27.78%1 Year Performance-22.38% Receive JYNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Huge AlertsThe #1 Biotech Stock to Have on Your Radar in 2024… Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!Learn more about why Zack’s has a BULLISH nearly $19 price target on BSEM right now! JYNT Stock Chart for Wednesday, April, 24, 2024 JYNT Chart by TradingView Joint Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/23/2024$12.36$12.59+1.86%$12.66$12.2945,765 shs$186.08 million04/22/2024$12.18$12.36+1.48%$12.54$12.1430,740 shs$182.68 million04/19/2024$11.92$12.18+2.18%$12.20$11.8371,591 shs$180.02 million04/18/2024$12.02$11.92-0.83%$12.09$11.8072,430 shs$176.18 million04/17/2024$12.00$12.02+0.17%$12.26$11.8651,983 shs$177.66 million04/16/2024$12.00$12.00$12.08$11.8534,104 shs$177.36 million Get the Latest News and Ratings for JYNT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Joint and its competitors with MarketBeat's FREE daily newsletter. 04/15/2024$12.15$12.00-1.23%$12.18$11.8569,572 shs$177.36 million04/12/2024$12.67$12.15-4.10%$12.60$12.1150,116 shs$179.58 million04/11/2024$12.40$12.67+2.18%$12.75$12.2447,338 shs$187.21 million04/10/2024$13.09$12.40-5.27%$12.81$12.3264,551 shs$183.22 million04/09/2024$12.91$13.09+1.39%$13.39$12.9751,805 shs$193.47 million04/08/2024$12.74$12.91+1.33%$13.00$12.7354,967 shs$190.81 million04/05/2024$12.70$12.74+0.31%$12.75$12.5322,720 shs$188.25 million04/04/2024$12.76$12.70-0.47%$13.06$12.6150,177 shs$187.71 million04/03/2024$12.55$12.76+1.67%$13.01$12.5061,039 shs$188.59 million04/02/2024$12.80$12.55-1.95%$12.67$12.2296,410 shs$185.49 million04/01/2024$13.06$12.80-1.99%$13.19$12.4193,803 shs$189.18 million03/29/2024$13.06$13.06$13.29$12.6863,876 shs$193.03 million03/28/2024$12.77$13.06+2.27%$13.29$12.6863,876 shs$193.03 million03/27/2024$12.47$12.77+2.41%$12.80$12.4150,212 shs$188.74 million03/26/2024$12.72$12.47-1.97%$12.91$12.4255,983 shs$184.31 million03/25/2024$12.97$12.72-1.93%$13.21$12.7043,294 shs$187.95 million03/22/2024$12.87$12.97+0.78%$13.21$12.7343,028 shs$191.70 million03/21/2024$12.79$12.87+0.63%$13.11$12.6958,716 shs$190.22 million03/20/2024$13.09$12.79-2.29%$13.31$12.5271,695 shs$188.99 million03/19/2024$12.29$13.09+6.51%$13.40$12.13170,466 shs$193.47 million03/18/2024$12.75$12.29-3.61%$12.71$12.0876,143 shs$181.65 million03/15/2024$11.80$12.75+8.05%$12.86$11.81155,827 shs$188.45 million03/14/2024$11.97$11.80-1.42%$12.16$11.76106,656 shs$174.40 million03/13/2024$12.27$11.97-2.44%$12.51$11.93127,589 shs$176.92 million03/12/2024$13.08$12.27-6.19%$13.07$12.24147,980 shs$180.98 million03/11/2024$11.88$13.08+10.10%$13.37$11.75303,817 shs$192.98 million03/08/2024$9.14$11.88+29.98%$13.69$9.62859,070 shs$175.23 million03/07/2024$9.45$9.14-3.28%$9.43$9.10167,171 shs$134.82 million03/06/2024$9.15$9.45+3.28%$9.57$9.2246,077 shs$139.43 million03/05/2024$9.34$9.15-2.03%$9.32$9.13118,746 shs$134.96 million03/04/2024$9.89$9.34-5.56%$10.03$9.24160,789 shs$137.77 million03/01/2024$9.86$9.89+0.30%$10.16$9.8095,322 shs$145.88 million02/29/2024$9.75$9.86+1.13%$9.93$9.7944,402 shs$145.44 million02/28/2024$9.84$9.75-0.91%$9.81$9.6547,384 shs$143.81 millionThe #1 Biotech Stock to Have on Your Radar in 2024… (Ad)Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!Learn more about why Zack’s has a BULLISH nearly $19 price target on BSEM right now!02/27/2024$9.99$9.84-1.50%$10.29$9.8353,918 shs$145.14 million02/26/2024$9.83$9.99+1.63%$10.03$9.7833,897 shs$147.35 million02/23/2024$10.06$9.83-2.29%$10.13$9.68113,167 shs$144.99 million02/22/2024$10.06$10.06$10.18$10.0064,417 shs$148.39 million02/21/2024$10.29$10.06-2.24%$10.47$10.0060,696 shs$148.43 million02/20/2024$10.41$10.29-1.15%$10.42$10.2974,010 shs$151.78 million02/19/2024$10.41$10.41$10.53$10.1673,800 shs$153.55 million02/16/2024$10.41$10.41$10.53$10.1673,877 shs$153.59 million02/15/2024$10.00$10.41+4.10%$10.45$9.9491,081 shs$153.55 million02/14/2024$10.00$10.00$10.17$9.9072,338 shs$147.50 million02/13/2024$10.95$10.00-8.68%$10.73$9.93115,851 shs$147.50 million02/12/2024$10.62$10.95+3.11%$11.17$10.5897,049 shs$161.51 million02/09/2024$9.80$10.62+8.37%$10.67$9.7872,489 shs$156.65 million02/08/2024$9.56$9.80+2.51%$9.83$9.5336,571 shs$144.55 million02/07/2024$9.62$9.56-0.62%$9.73$9.4076,898 shs$141.01 million02/06/2024$9.51$9.62+1.16%$9.67$9.31133,811 shs$141.93 million02/05/2024$9.90$9.51-3.94%$9.86$9.5186,784 shs$140.27 million02/02/2024$10.09$9.90-1.88%$10.07$9.8766,823 shs$146.03 million02/01/2024$9.76$10.09+3.38%$10.19$9.7790,294 shs$148.83 million01/31/2024$9.77$9.76-0.10%$10.04$9.6772,029 shs$143.96 million01/30/2024$9.73$9.77+0.41%$9.86$9.5249,804 shs$144.11 million01/29/2024$9.46$9.73+2.85%$9.77$9.3673,888 shs$143.52 million01/26/2024$9.39$9.46+0.75%$9.64$9.3352,035 shs$139.54 million01/25/2024$9.39$9.39$9.52$9.2349,722 shs$138.50 million01/24/2024$9.63$9.39-2.49%$9.73$9.3485,988 shs$138.50 million01/23/2024$9.39$9.63+2.56%$9.70$9.3869,305 shs$142.04 million Related Companies: Cardiff Oncology Stock Chart Veru Stock Chart Atossa Therapeutics Stock Chart Akoya Biosciences Stock Chart INmune Bio Stock Chart Alimera Sciences Stock Chart Profound Medical Stock Chart 908 Devices Stock Chart Acumen Pharmaceuticals Stock Chart Semler Scientific Stock Chart Receive JYNT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:JYNT) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Joint Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.